CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities:
Net loss	$ (254,663)	$ (266,822)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of patents and proprietary technology		6,822
Amortization of discount on note payable		31,324
Depreciation	560	560
Change in fair value of derivative liabilities		34,537
Changes in operating assets and liabilities:
Accounts receivable	2,434	(1,230)
Prepaid expenses and other assets	4,603	2,548
Accounts payable	19,290	9,098
Accounts payable - related parties	(2,197)	19,000
Accrued liabilities	99,932	105,513
Net Cash Used in Operating Activities	(130,041)	(58,650)
Cash Flows from Investing Activities:
Net Cash Used in Investing Activities
Cash Flows from Financing Activities:
Proceeds from borrowings under convertible note payable		50,000
Net Cash Provided by Financing Activities		50,000
Net Change in Cash and Cash Equivalents	(130,041)	(8,650)
Cash and Cash Equivalents at Beginning of Period	170,004	17,798
Cash and Cash Equivalents at End of Period	39,963	9,148
Supplemental Cash Flow Information:
Cash paid for income taxes
Cash paid for interest
Supplemental Disclosure on Noncash Investing and Financing Activities
Recognition of discounts on convertible notes payable		$ 17,758